Abivax CEO Downplays Sale Talk, Eyes Capital Raise As Key Trial Data Readout Nears

Benzinga_recent_news03-25

• Abivax stock is taking a hit today. Why is ABVX stock falling? The French biotech firm has been at the center of takeover rumors for months, with analysts identifying it as a potential acquisition ...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment